TERC and cancer: Telomerase reactivation, a hallmark of cancer, not only maintains telomere length via its core components TERT and TERC, but also exerts non-canonical mitochondrial functions—reducing ROS, DNA damage, and apoptosis (Liu et al., 2023; Jaiswal et al., 2013).